A new trajectory planning system developed by MIT researchers formally guarantees that an uncrewed aerial vehicle’s flight path will remain safe from collisions, even in unmapped environments with unknown moving obstacles. 

Los Angeles, CA – October 07, 2026 - The Terasaki Institute for Biomedical Innovation announced today that OnVagus, a medical device company incubating at the Institute, has received institutional and regulatory approval to begin the first human trial of its noninvasive nerve-stimulation device for patients experiencing cancer-related wasting.

Researchers at South China University of Technology, in collaboration with the Dongguan Institute of Materials Science and Technology, Chinese Academy of Sciences, have developed a novel supranano multi-precipitate microstructure in amorphous soft magnetic composites using Ar/O₂ plasma treatment. By facilitating magnetic-moment reversal, this approach significantly reduced the coercivity while maintaining  excellent overall performance. The optimized material exhibits an ultralow coercivity of 0.13 Oe, an effective permeability of 37.3, a high saturation magnetization of 185 emu g^-1 and an ultralow core loss of 191.18 kW m⁻³ at 1 MHz and 20 mT. These results provide for a promising strategy for developing next-generation soft magnetic composites for miniaturized, high-frequency, and high-efficiency power electronics devices.

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.